Enhancer-targeted CRISPR-Activation Rescues Haploinsufficient Autism Susceptibility Genes DOI Open Access
George Chen,

Gayatri Nair,

Aubrey J. Osorio

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: March 14, 2024

Abstract Autism Spectrum Disorder (ASD) is a highly heritable condition with diverse clinical presentations. Approximately 20% of ASD’s genetic susceptibility imparted by de novo mutations major effect, most which cause haploinsufficiency. We mapped enhancers two high confidence autism genes – CHD8 and SCN2A used CRISPR-based gene activation (CRISPR-A) in hPSC-derived excitatory neurons cerebral forebrain organoids to correct the effects haploinsufficiency, taking advantage presence wildtype allele each endogenous regulation. found that CRISPR-A induced sustained increase expression treated organoids, rescue levels mutation-associated phenotypes, including physiology. These data support via targeting haploinsufficient genes, as therapeutic intervention ASD other neurodevelopmental disorders.

Language: Английский

Genetic testing education needs among parents of children with autism spectrum disorder in Taiwan: a qualitative investigation DOI
Meng Xiao,

Ssu-Yu Yeh,

Zihan Zhang

et al.

Journal of Community Genetics, Journal Year: 2025, Volume and Issue: unknown

Published: April 29, 2025

Language: Английский

Citations

0

Reproductive and cognitive phenotypes in carriers of recessive pathogenic variants DOI
Hila Fridman, Gelana Khazeeva, Ephrat Levy‐Lahad

et al.

Nature Human Behaviour, Journal Year: 2025, Volume and Issue: unknown

Published: May 15, 2025

Language: Английский

Citations

0

European Autism GEnomics Registry (EAGER): protocol for a multicentre cohort study and registry DOI Creative Commons
Madeleine Bloomfield, Alexandra Lautarescu, Síofra Heraty

et al.

BMJ Open, Journal Year: 2024, Volume and Issue: 14(6), P. e080746 - e080746

Published: June 1, 2024

Autism is a common neurodevelopmental condition with complex genetic aetiology that includes contributions from monogenic and polygenic factors. Many autistic people have unmet healthcare needs could be served by genomics-informed research clinical trials. The primary aim of the European GEnomics Registry (EAGER) to establish registry participants diagnosis autism or an associated rare who undergone whole-genome sequencing. can facilitate recruitment for future trials studies, based on genetic, phenotypic profiles, as well participant preferences. secondary EAGER investigate association between mental physical health characteristics participants' profiles.

Language: Английский

Citations

2

From Symptomatology to Functioning - Applying the ICF to Autism Measures to Facilitate Neurodiversity-Affirmative Data Harmonization DOI Creative Commons
Melissa H. Black, Karl Lundin Remnélius, Lovisa Alehagen

et al.

Journal of Autism and Developmental Disorders, Journal Year: 2023, Volume and Issue: unknown

Published: Dec. 11, 2023

A considerable number of screening and diagnostic tools for autism exist, but variability in these measures presents challenges to data harmonization the comparability generalizability findings. At same time, there is a movement away from symptomatology stances that capture heterogeneity appreciate diversity. The International Classification Functioning, Disability Health (ICF) provides classification system can support content different while enabling translation information into functioning.Here we linked commonly used within field ICF facilitate unification obtained measures.As expected, primarily focus on body functions activities participation domains ICF, much less environmental factors, reflecting biomedical adaptive behavior operationalizations derived manuals.By translating symptomology-based continuous diagnostically neutral view functioning, linking presented here may provide means harmonize characteristics be re-examined through more neurodiversity-affirmative lens.

Language: Английский

Citations

6

Enhancer-targeted CRISPR-Activation Rescues Haploinsufficient Autism Susceptibility Genes DOI Open Access
George Chen,

Gayatri Nair,

Aubrey J. Osorio

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: March 14, 2024

Abstract Autism Spectrum Disorder (ASD) is a highly heritable condition with diverse clinical presentations. Approximately 20% of ASD’s genetic susceptibility imparted by de novo mutations major effect, most which cause haploinsufficiency. We mapped enhancers two high confidence autism genes – CHD8 and SCN2A used CRISPR-based gene activation (CRISPR-A) in hPSC-derived excitatory neurons cerebral forebrain organoids to correct the effects haploinsufficiency, taking advantage presence wildtype allele each endogenous regulation. found that CRISPR-A induced sustained increase expression treated organoids, rescue levels mutation-associated phenotypes, including physiology. These data support via targeting haploinsufficient genes, as therapeutic intervention ASD other neurodevelopmental disorders.

Language: Английский

Citations

2